Carboxyalkylethers, formulations, and treatment of vascular dise

Details Carboxyalkylethers, formulations, and treatment of vascular dise Carboxyalkylethers, formulations, and treatment of vascular dise

1997-02-25

1998-05-26

Shippen, Michael L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

514381, 514531, 514533, 514544, 514546, 514557, 514571, 514572, 514693, 514699, 514529, 514530, 514547, 514573, 514574, A61K 31225

Patent

active

057565449

ABSTRACT:
Dialkyl ethers lower Lp(a) and triglycerides, and elevate HDL-cholesterol, and are thereby useful for treating vascular diseases and noninsulin-dependent diabetes mellitus.

REFERENCES:
patent: 3320079 (1967-05-01), Perry et al.
patent: 3674836 (1972-07-01), Creger
patent: 3703549 (1972-11-01), Yeomans
patent: 3742068 (1973-06-01), Moersch et al.
patent: 3930024 (1975-12-01), Creger
patent: 4454145 (1984-06-01), Cristofori et al.
patent: 4711896 (1987-12-01), Bar-Tana et al.
patent: 4990227 (1991-02-01), Steiniger et al.
Lipids, vol. 12, No. 1, 1976, Blumenthal et al., pp. 44-48.
Diabetes, vol. 37, 1988, Tzur et al., pp. 1618-1624.
Supplement to Circulation, vol. 84, No. 4, 1991, Jones et al., Abstract 1925.
Current Therapeutic Research, vol. 49, No. 4, 1991, Bimmermann et al., pp. 635-643.
Antilipidemic Drugs, Medicinal, Chemical and Biochemical Aspects, Elsevier Science Publishers B.V., Amsterdam, Witiak D.T. et al. (Editors), Chapter 8, Roth et al., pp. 225-255.
J. Clin. Invest., vol. 95, 1995, Staels et al., pp. 705-712.
Endocrinology, vol. 133, No. 1, 1993, Sandouk et al., pp. 352-359.
The Journal of Biological Chemistry, vol. 260, No. 5, 1985, Frost et al., pp. 2646-2652.

Affiliated with

Also associated with

Rating

Carboxyalkylethers, formulations, and treatment of vascular dise does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Carboxyalkylethers, formulations, and treatment of vascular dise, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carboxyalkylethers, formulations, and treatment of vascular dise will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1960758